arGentis Pharmaceuticals
Collierville, Tennessee, United States
About arGentis Pharmaceuticals
arGentis Pharmaceuticals, LLS is a private TN based pharmaceutical company with a mid-stage Orphan Drug treatment (ARG201) for late stage diffuse systemic scleroderma (dcSSc). The company is seeking capital to complete a Pivotal Clinical Trial which will enable obtaining marketing approval in the EU. The Company has a genotype marker (ROT1) that predicts patient response to treatment by oral tolerance for treatments like ARG201 for dcSSc.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $500.0K
- Last round: Series Unknown (Mar 2008)
- Website: argentisrx.com
- Phone: (901)881-8665
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/argentis-pharmaceuticals-2499087 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.